NovoCure Limited Operating Income
NovoCure Limited (NVCR) reported Operating Income of -$10.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-23
- NovoCure Limited operating income (loss) for the quarter ending 2026-06-30 was -$10.56M.
- NovoCure Limited operating income (loss) for the quarter ending 2026-03-31 was -$67.42M.
- NovoCure Limited operating income (loss) for the quarter ending 2025-12-31 was -$40.39M.
- NovoCure Limited operating income (loss) for the quarter ending 2025-09-30 was -$36.02M.
- NovoCure Limited operating income (loss) for fiscal 2024 was -$170.50M.
- NovoCure Limited operating income (loss) for fiscal 2023 was -$232.87M.
- NovoCure Limited operating income (loss) for fiscal 2022 was -$89.52M.
- NovoCure Limited operating income (loss) for fiscal 2021 was -$44.33M, a 245.83% decline from fiscal 2020.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.56M 10-Q · filed 2026-07-23 | -$77.98M 10-Q · filed 2026-07-23 | -$118.38M derived: sum of 3 quarters · filed 2026-07-23 | -$154.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$67.42M 10-Q · filed 2026-04-30 | -$107.81M derived: sum of 2 quarters · filed 2026-07-23 | -$143.83M derived: sum of 3 quarters · filed 2026-07-23 | -$183.35M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$40.39M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | -$76.41M derived: sum of 2 quarters · filed 2026-07-23 | -$115.94M derived: sum of 3 quarters · filed 2026-07-23 | -$153.80M 10-Q · filed 2026-07-23 |
| 2025-09-30 | -$36.02M 10-Q · filed 2025-10-30 | -$75.54M derived: sum of 2 quarters · filed 2026-07-23 | -$113.41M 10-Q · filed 2025-10-30 | -$176.71M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | -$39.52M 10-Q · filed 2026-07-23 | -$77.39M 10-Q · filed 2026-07-23 | -$140.69M derived: sum of 3 quarters · filed 2026-07-23 | -$172.78M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | -$37.87M 10-Q · filed 2026-04-30 | -$101.17M derived: sum of 2 quarters · filed 2026-04-30 | -$133.26M derived: sum of 3 quarters · filed 2026-04-30 | -$166.84M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$63.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$95.40M derived: sum of 2 quarters · filed 2026-02-26 | -$128.98M derived: sum of 3 quarters · filed 2026-02-26 | -$170.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$32.09M 10-Q · filed 2025-10-30 | -$65.67M derived: sum of 2 quarters · filed 2025-10-30 | -$107.19M 10-Q · filed 2025-10-30 | -$158.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$33.58M 10-Q · filed 2025-07-24 | -$75.10M 10-Q · filed 2025-07-24 | -$126.82M derived: sum of 3 quarters · filed 2026-02-26 | -$185.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$41.52M 10-Q · filed 2025-04-24 | -$93.24M derived: sum of 2 quarters · filed 2026-02-26 | -$151.48M derived: sum of 3 quarters · filed 2026-02-26 | -$214.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$51.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$109.96M derived: sum of 2 quarters · filed 2026-02-26 | -$172.62M derived: sum of 3 quarters · filed 2026-02-26 | -$232.87M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$58.24M 10-Q · filed 2024-10-30 | -$120.91M derived: sum of 2 quarters · filed 2024-10-30 | -$181.15M 10-Q · filed 2024-10-30 | -$224.13M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$62.66M 10-Q · filed 2024-07-25 | -$122.91M 10-Q · filed 2024-07-25 | -$165.89M derived: sum of 3 quarters · filed 2024-07-25 | -$190.50M derived: sum of 4 quarters · filed 2024-07-25 |
| 2023-03-31 | -$60.25M 10-Q · filed 2024-05-02 | -$103.23M derived: sum of 2 quarters · filed 2024-05-02 | -$127.84M derived: sum of 3 quarters · filed 2024-05-02 | -$148.97M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$42.98M 10-K · filed 2023-02-23 | -$67.59M derived: sum of 2 quarters · filed 2023-10-26 | -$88.72M derived: sum of 3 quarters · filed 2023-10-26 | -$89.52M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$24.61M 10-Q · filed 2023-10-26 | -$45.74M derived: sum of 2 quarters · filed 2023-10-26 | -$46.55M 10-Q · filed 2023-10-26 | -$69.94M derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-06-30 | -$21.13M 10-Q · filed 2023-07-27 | -$21.93M 10-Q · filed 2023-07-27 | -$45.33M derived: sum of 3 quarters · filed 2023-07-27 | -$53.88M derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | -$806.00K 10-Q · filed 2023-05-04 | -$24.20M derived: sum of 2 quarters · filed 2023-05-04 | -$32.76M derived: sum of 3 quarters · filed 2023-05-04 | -$45.05M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$23.40M 10-K · filed 2023-02-23 | -$31.95M derived: sum of 2 quarters · filed 2023-02-23 | -$44.24M derived: sum of 3 quarters · filed 2023-02-23 | -$44.33M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$8.55M 10-K · filed 2023-02-23 | -$20.85M derived: sum of 2 quarters · filed 2023-02-23 | -$20.93M 10-Q · filed 2022-10-27 | -$8.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$12.29M 10-K · filed 2023-02-23 | -$12.38M 10-Q · filed 2022-07-28 | -$291.00K derived: sum of 3 quarters · filed 2023-02-23 | $14.73M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$88.00K 10-K · filed 2023-02-23 | $12.00M derived: sum of 2 quarters · filed 2023-02-23 | $27.03M derived: sum of 3 quarters · filed 2023-02-23 | $33.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $12.09M 10-K · filed 2023-02-23 | $27.11M derived: sum of 2 quarters · filed 2023-02-23 | $33.78M derived: sum of 3 quarters · filed 2023-02-23 | $30.40M 10-K · filed 2023-02-23 |
| 2020-09-30 | $15.02M 10-K · filed 2023-02-23 | $21.69M derived: sum of 2 quarters · filed 2023-02-23 | $18.31M 10-Q · filed 2021-10-28 | $18.46M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-06-30 | $6.67M 10-K · filed 2023-02-23 | $3.29M 10-Q · filed 2021-07-29 | $3.44M derived: sum of 3 quarters · filed 2023-02-23 | $7.29M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-03-31 | -$3.38M 10-K · filed 2023-02-23 | -$3.23M derived: sum of 2 quarters · filed 2023-02-23 | $627.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.82M derived: sum of 4 quarters · filed 2023-02-23 |
| 2019-12-31 | $153.00K 10-K · filed 2022-02-24 | $4.01M derived: sum of 2 quarters · filed 2022-02-24 | $5.20M derived: sum of 3 quarters · filed 2022-02-24 | -$914.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $3.85M 10-K · filed 2022-02-24 | $5.05M derived: sum of 2 quarters · filed 2022-02-24 | -$1.07M 10-Q · filed 2020-10-29 | -$9.73M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-06-30 | $1.20M 10-K · filed 2022-02-24 | -$4.92M 10-Q/A · filed 2020-10-02 | -$13.59M derived: sum of 3 quarters · filed 2022-02-24 | -$18.83M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-03-31 | -$6.12M 10-K · filed 2022-02-24 | -$14.78M derived: sum of 2 quarters · filed 2022-02-24 | -$20.03M derived: sum of 3 quarters · filed 2022-02-24 | -$27.11M derived: sum of 4 quarters · filed 2022-02-24 |
| 2018-12-31 | -$8.66M 10-K · filed 2021-02-25 | -$13.91M derived: sum of 2 quarters · filed 2021-02-25 | -$21.00M derived: sum of 3 quarters · filed 2021-02-25 | -$33.67M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$5.25M 10-K · filed 2021-02-25 | -$12.33M derived: sum of 2 quarters · filed 2021-02-25 | -$25.01M 10-Q · filed 2019-10-31 | -$29.51M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-06-30 | -$7.08M 10-K · filed 2021-02-25 | -$19.76M 10-Q · filed 2019-07-25 | -$24.27M derived: sum of 3 quarters · filed 2021-02-25 | -$30.19M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-03-31 | -$12.68M 10-K · filed 2021-02-25 | -$17.18M derived: sum of 2 quarters · filed 2021-02-25 | -$23.10M derived: sum of 3 quarters · filed 2021-02-25 | -$38.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2017-12-31 | -$4.51M 10-K · filed 2020-02-27 | -$10.43M derived: sum of 2 quarters · filed 2020-02-27 | -$25.95M derived: sum of 3 quarters · filed 2020-02-27 | -$39.33M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$5.92M 10-K · filed 2020-02-27 | -$21.45M derived: sum of 2 quarters · filed 2020-02-27 | -$34.82M 10-Q · filed 2018-10-25 | -$52.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-06-30 | -$15.53M 10-K · filed 2020-02-27 | -$28.90M 10-Q · filed 2018-07-26 | -$46.78M derived: sum of 3 quarters · filed 2020-02-27 | -$75.05M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-03-31 | -$13.37M 10-K · filed 2020-02-27 | -$31.25M derived: sum of 2 quarters · filed 2020-02-27 | -$59.52M derived: sum of 3 quarters · filed 2020-02-27 | -$96.75M derived: sum of 4 quarters · filed 2020-02-27 |
| 2016-12-31 | -$17.88M 10-K · filed 2019-02-28 | -$46.14M derived: sum of 2 quarters · filed 2019-02-28 | -$83.38M derived: sum of 3 quarters · filed 2019-02-28 | -$115.32M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$28.27M 10-K · filed 2019-02-28 | -$65.50M derived: sum of 2 quarters · filed 2019-02-28 | -$97.44M 10-Q · filed 2017-10-26 | -$128.05M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-06-30 | -$37.24M 10-K · filed 2019-02-28 | -$69.17M 10-Q · filed 2017-07-27 | -$99.78M derived: sum of 3 quarters · filed 2019-02-28 | -$124.02M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-03-31 | -$31.94M 10-K · filed 2019-02-28 | -$62.54M derived: sum of 2 quarters · filed 2019-02-28 | -$86.78M derived: sum of 3 quarters · filed 2019-02-28 | -$113.99M derived: sum of 4 quarters · filed 2019-02-28 |
| 2015-12-31 | -$30.61M 10-K · filed 2017-02-23 | -$54.84M derived: sum of 2 quarters · filed 2017-02-23 | -$82.05M derived: sum of 3 quarters · filed 2017-02-23 | -$104.00M 10-K · filed 2018-02-22 |
| 2015-09-30 | -$24.24M 10-K · filed 2017-02-23 | -$51.44M derived: sum of 2 quarters · filed 2017-02-23 | -$73.39M 10-Q · filed 2016-11-02 | -$96.40M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$27.21M 10-K · filed 2017-02-23 | -$49.15M 10-Q · filed 2016-07-28 | -$72.16M derived: sum of 3 quarters · filed 2017-02-23 | -$90.07M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$21.95M 10-K · filed 2017-02-23 | -$44.95M derived: sum of 2 quarters · filed 2017-02-23 | -$62.86M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$23.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$40.91M derived: sum of 2 quarters · filed 2017-02-23 | -$80.16M 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$17.91M 10-Q · filed 2015-10-27 | -$57.15M 10-Q · filed 2015-10-27 | ||
| 2013-12-31 | -$64.46M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |